InvestorsHub Logo
Followers 275
Posts 32727
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Tuesday, 02/25/2014 2:52:28 PM

Tuesday, February 25, 2014 2:52:28 PM

Post# of 704264
ITMN went from 13.00 to 37.00 today on successful phase III trial for fibrotic lung treatment which doubles overall survival. The drug has been improved in Europe for a few years now, so the results are not that surprising, but the price spike is. Many people will live longer and healthier lives due to this drug.


NWBO: Unexecised warrants, options plus outstanding shares = 72 million
POTENTIAL APPLICATION: APPROXIMATELY 15 MILLION PATIENTS IN U.S.

ITMN: " " = 82 million
POTENTIAL APPLICATION: 135,00 TO 500,000 PATIENTS IN U.S.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News